BRIEF published on 10/24/2025 at 07:05, 5 months 11 days ago Surperformance de BB Biotech au troisième trimestre 2025 dans un contexte de reprise sectorielle BB Biotech Performances Du Troisième Trimestre 2025 Indice Nasdaq Biotechnology Thérapies À Base D'ARN Reprise Du Secteur
BRIEF published on 10/24/2025 at 07:05, 5 months 11 days ago BB Biotech's Q3 2025 Outperformance Amid Sector Recovery Sector Recovery BB Biotech Q3 2025 Performance Nasdaq Biotechnology Index RNA-based Therapeutics
PRESS RELEASE published on 10/24/2025 at 07:00, 5 months 11 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes interim report for the first nine months of 2025, reporting CHF 106 mn net profit. More details at report.bbbiotech.ch/Q325 Financial Results Investment Company Net Profit BB Biotech AG Interim Report
PRESS RELEASE published on 10/24/2025 at 07:00, 5 months 11 days ago BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery BB Biotech AG reports strong Q3 2025 performance with portfolio outperforming Nasdaq Biotech Index, driven by solid net profit, key company milestones, and strategic investments BB Biotech AG Interim Report Sector Recovery Q3 2025 Portfolio Outperformance
BRIEF published on 09/22/2025 at 07:05, 6 months 12 days ago BB Biotech Joins SPI ESG Index Biotechnology Swiss Exchange BB Biotech Sustainable Investing SPI ESG Index
BRIEF published on 09/22/2025 at 07:05, 6 months 12 days ago BB Biotech rejoint l'indice SPI ESG Biotechnologie Bourse Suisse Investissement Durable BB Biotech Indice SPI ESG
PRESS RELEASE published on 09/22/2025 at 07:00, 6 months 12 days ago BB Biotech to be included in the SPI ESG Index BB Biotech AG to be included in the SPI ESG Index by SIX Swiss Exchange, highlighting commitment to sustainability and responsible investing Sustainability SIX Swiss Exchange BB Biotech AG SPI ESG Index Responsible Investing
BRIEF published on 07/25/2025 at 07:05, 8 months 10 days ago BB Biotech AG Reports Interim Loss Net Loss Investment Portfolio Interim Report BB Biotech 2025 Financial Results
BRIEF published on 07/25/2025 at 07:05, 8 months 10 days ago BB Biotech AG annonce une perte intermédiaire Perte Nette Portefeuille D'investissement BB Biotech Rapport Intermédiaire Résultats Financiers 2025
BRIEF published on 07/25/2025 at 07:05, 8 months 10 days ago Aperçu des performances financières de BB Biotech au deuxième trimestre 2025 Innovation Stratégie De Portefeuille BB Biotech Acquisition De Sanofi Performances Du Deuxième Trimestre 2025
Published on 04/02/2026 at 22:00, 1 day 17 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day 20 hours ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 2 days ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 days ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 days ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 5 hours 22 minutes ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 13 hours 23 minutes ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 21 hours 29 minutes ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 21 hours 29 minutes ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 21 hours 43 minutes ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 18:46, 20 hours 42 minutes ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 20 hours 42 minutes ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 21 hours 27 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 21 hours 29 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 21 hours 29 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
